Can an oral drug help people with fatty liver disease? Early safety study begins.

For people living with NASH, a progressive form of fatty liver disease that can lead to scarring and liver failure, treatment options are limited. A new, early-stage study has begun testing whether an oral drug called idebenone might one day help. The study involved 53 adults with NASH and early to moderate liver scarring. They received either the drug or a placebo for up to 48 weeks, starting with a low dose that was gradually increased. The main goal was simply to check for safety and side effects, not to prove the drug works. This is a crucial first step, but it's important to know that the results for safety, side effects, and any potential impact on liver scarring have not been reported yet. This was a small, single-center study, which means we need much larger and longer trials to understand if this drug is truly safe and effective.